Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22345382 | 0.78 | GPR3 (0.39) | CYP1A2CYP2C19ALDH1A1SMN1; SMN2GPR3 | |
| SCHEMBL10742424 | 0.77 | GPR3 (0.41) | ALDH1A1GPR3TGFBR1HCRTR1HCRTR2 | |
| SCHEMBL22345497 | 0.74 | ALDH1A1 (0.36) | CYP1A2CYP2C19ALDH1A1GPR3TGFBR1 | |
| SCHEMBL22345431 | 0.73 | MEN1 (0.42) | CYP1A2ALDH1A1SMN1; SMN2GPR3 | |
| SCHEMBL22345518 | 0.71 | MEN1 (0.36) | CYP1A2ALDH1A1SMN1; SMN2GPR3 | |
| SCHEMBL4546577 | 0.69 | GPR3 (0.44) | CYP1A2CYP2C19ALDH1A1SMN1; SMN2GPR3 | |
| SCHEMBL19841858 | 0.69 | IDO1 (0.43) | CYP1A2CYP2C19ALDH1A1SMN1; SMN2GPR3 | |
| SCHEMBL11278441 | 0.69 | SMN1; SMN2 (0.34) | CYP1A2CYP2C19ALDH1A1SMN1; SMN2GPR3 | |
| SCHEMBL9114839 | 0.67 | GPR3 (0.46) | CYP1A2CYP2C19ALDH1A1SMN1; SMN2GPR3 | |
| SCHEMBL14518818 | 0.67 | ELANE (0.41) | CYP1A2CYP2C19ALDH1A1SMN1; SMN2GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220132847-A1 | CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | SYNGENTA CROP PROTECTION AG (CH) | 2022-05-05 | — | — | US | disclosed |
| EP-3924344-A1 | CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | Syngenta Crop Protection AG (CH) | 2021-12-22 | — | — | EP | disclosed |
| CN-113423694-A | Cinnolinium compounds for use in a method for controlling unwanted plant growth | 先正达农作物保护股份公司 | 2021-09-21 | — | — | CN | disclosed |
| WO-2020164970-A1 | CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | SYNGENTA CROP PROTECTION AG (CH) | 2020-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220132847-A1 | CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | NOTUM, DDT, CYP51A1 | CYP1A2 121/4885CYP2C19 356/4885ALDH1A1 244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.